EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

rpoB mutations and their association with rifampicin resistance in clinical Staphylococcus epidermidis

Sofie Marie Edslev, Mia Aarris iD, Karen Leth Nielsen, Frederik B Hertz, Thor Bech Johannesen, Camille Kolenda iD, Frederic Laurent iD, Emeli Månsson, Bo Söderquist iD, Marc Stegger

Journal of Antimicrobial Chemotherapy · 2025

DOI: 10.1093/jac/dkaf035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2025. Verfasst von Sofie Marie Edslev und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Sequencing and Bioinformatics, Statens Serum Institut, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Rifampin, Staphylococcus epidermidis, Drug Resistance, Bacterial, DNA-Directed RNA Polymerases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nyckelfonden at Örebro University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Staphylococcus epidermidis is a ubiquitous member of the healthy skin and mucous microbiota but is also an opportunistic pathogen responsible for various infections, often treated with antibiotics like rifampicin. Resistance to rifampicin in S. epidermidis arises primarily through nonsynonymous mutations in the rpoB gene.

Objectives

To investigate the prevalence of rpoB mutations and their association with phenotypic rifampicin resistance in clinical S. epidermidis isolates from Denmark, France, and Sweden.

Methods

All clinical isolates (N = 942) were whole-genome sequenced to identify mutations in rpoB and subsequently linked to phenotypic rifampicin resistance based on antimicrobial susceptibility testing.

Results

A total of 64 (6.8%) isolates were resistant to rifampicin. They carried all mutational changes in the rifampicin resistance-determining region (RRDR). Among 12 identified nonsynonymous mutations, 11 were exclusively observed in resistant strains, including novel mutations not previously described in S. epidermidis.

Conclusions

This study highlights the diverse genetic variants of rpoB associated with rifampicin resistance in clinical S. epidermidis isolates, including novel mutations. The strong correlation between mutational changes in RRDR and phenotypic resistance reinforces the role of rpoB mutations as a primary mechanism of resistance in clinical isolates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RifampinStaphylococcus epidermidisDrug Resistance, BacterialDNA-Directed RNA PolymerasesAnti-Bacterial AgentsMutationBacterial ProteinsHumansMicrobial Sensitivity TestsStaphylococcal InfectionsWhole Genome SequencingSwedenDenmarkFrance

Substanzen

RifampinDNA-Directed RNA PolymerasesAnti-Bacterial AgentsRNA polymerase beta subunitBacterial Proteins

Autor:innen und Institutionen

  • Department of Sequencing and Bioinformatics, Statens Serum Institut, Copenhagen, Denmark.
  • European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Staphylococci and Staphylococcal Diseases (ESGS), Basel, Switzerland.
  • Department of Clinical Microbiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
  • Department of Immunology & Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Service de Bactériologie, Centre National de Référence des Staphylocoques, Institut des Agents Infectieux, Hospices Civils de Lyon, Lyon, France.
  • Equipe StaPath, CIRI, Centre International de Recherche en Infectiologie, Université de Lyon, Lyon, France.

ORCID-Profile: Mia Aarris, Camille Kolenda, Frederic Laurent, Bo Söderquist

Förderung

  • Nyckelfonden at Örebro University Hospital

Zitieren

APA

Edslev, S. M., Aarris, M., Nielsen, K. L., Hertz, F. B., Johannesen, T. B., Kolenda, C., Laurent, F., Månsson, E., Söderquist, B., & Stegger, M. (2025). rpoB mutations and their association with rifampicin resistance in clinical Staphylococcus epidermidis. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkaf035

Vancouver

Edslev SM, Aarris M, Nielsen KL, Hertz FB, Johannesen TB, Kolenda C, et al. rpoB mutations and their association with rifampicin resistance in clinical Staphylococcus epidermidis. Journal of Antimicrobial Chemotherapy. 2025. doi:10.1093/jac/dkaf035

BibTeX
@article{Edslev2025,
  author = {Edslev, Sofie Marie and Aarris, Mia and Nielsen, Karen Leth and Hertz, Frederik B and Johannesen, Thor Bech and Kolenda, Camille and Laurent, Frederic and Månsson, Emeli and Söderquist, Bo and Stegger, Marc},
  title = {rpoB mutations and their association with rifampicin resistance in clinical Staphylococcus epidermidis},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2025},
  doi = {10.1093/jac/dkaf035}
}
Kostenlos starten →